In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...

But these drugs do expire after a few weeks, and microdosing could increase the risk of inadvertently using them after their ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss , and have ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...

Some of the more than a dozen states that cover GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid are scrambling ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Fourteen medical spas across Ohio are accused of misleading customers about their versions of weight loss drugs ...